- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01770496
Age-Specific Strategies for Immunization Reminders and Recalls
January 16, 2013 updated by: Kevin Dombkowski, University of Michigan
The objective of this study was to assess the relative effectiveness of reminder/recall strategies among children who live in an urban area targeting alternative age-specific milestones.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10175
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-5456
- University of Michigan, Child Health Evaluation and Research (CHEAR) Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 months to 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 7 and 19 month recall groups: children not up to date for at least one vaccination at the time of notification
- 12 month reminder group: 12 months of age at time of notification
- Hib vaccination series was not assessed due to a vaccine shortage
Exclusion Criteria:
- Children were ineligible for notifications if they were designated in the Michigan Care Improvement Registry (MCIR)as having died, documented previously as having moved out of the jurisdiction ("Moved or Gone Elsewhere" (MOGE)), opted out of MCIR by their parent, or if they had been previously mailed for MCIR reminder/recall activity in the prior 60 days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No reminder / recall notice
No childhood vaccination reminder / recall notification sent.
Stratified by age cohort of subjects: 7 month recall; 12 month reminder; 19 month recall
|
|
|
Experimental: mailed reminder / recall notice
Childhood vaccination reminder / recall notification sent by postal mail.
Stratified by age cohort of subjects: 7 month recall; 12 month reminder; 19 month recall
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
new immunization doses
Time Frame: within 60 days of reminder notification
|
Receipt of 1 or more childhood vaccinations with administration date following reminder notification date
|
within 60 days of reminder notification
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost of vaccination reminder
Time Frame: During the time of reminder notification preparation and mailing and approximately 1 month following mailing
|
Estimated personnel costs to generate reminder notifications, print, fold / stuff envelopes and follow up on undeliverable notifications
|
During the time of reminder notification preparation and mailing and approximately 1 month following mailing
|
|
historical immunization doses
Time Frame: within 60 days of reminder notification
|
One or more vaccination recorded with the date of administration prior to the reminder notification date
|
within 60 days of reminder notification
|
|
waived doses
Time Frame: within 60 days of reminder notification
|
One or more immunization waiver (non-administration) recorded with the date following the date of reminder notification
|
within 60 days of reminder notification
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kevin J Dombkowski, DrPH, MS, University of Michigan, Child Health Evaluation and Research (CHEAR) Unit
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (Actual)
September 1, 2009
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
January 15, 2013
First Submitted That Met QC Criteria
January 16, 2013
First Posted (Estimate)
January 17, 2013
Study Record Updates
Last Update Posted (Estimate)
January 17, 2013
Last Update Submitted That Met QC Criteria
January 16, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- U01IP000088-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Vaccination
-
Kaiser PermanenteSeattle Children's Hospital; Washington State, Department of Health; WithinReachCompleted
-
Necmettin Erbakan UniversityCompletedVaccine Hesitancy | Childhood VaccinationTurkey
-
Istanbul University - CerrahpasaActive, not recruitingChildhood ImmunizationTurkey (Türkiye)
-
Hospital Nossa Senhora da ConceicaoCompletedPain Due to Childhood VaccinationBrazil
-
University of RochesterUniversity of California, Los AngelesCompletedChildhood Influenza Vaccination | School-located Influenza VaccinationUnited States
-
University of California, Los AngelesUniversity of Rochester; Agency for Healthcare Research and Quality (AHRQ)CompletedChildhood Influenza Vaccination | School-located Influenza Vaccination
-
University of California, Los AngelesCompletedChildhood Influenza Vaccination | School-located Influenza VaccinationUnited States
-
Yuzuncu Yil UniversityCompletedHealth Education | Vaccine Hesitancy | Digital Health Literacy | Eco-anxiety | Childhood Immunization | Vulnerability to DiseaseTurkey (Türkiye)
-
Children's Cancer Group, ChinaShanghai Pudong District Center for Disease Control and PreventionRecruitingHematologic Malignancy | Solid Tumor, Childhood | VaccinationChina
-
University of Massachusetts, WorcesterRecruiting
Clinical Trials on Childhood vaccination reminder / recall notification
-
University of Colorado, DenverAgency for Healthcare Research and Quality (AHRQ)CompletedImmunization Reminder SystemUnited States
-
University of California, Los AngelesNational Cancer Institute (NCI); University of Colorado, DenverCompleted
-
University of Colorado, DenverNational Cancer Institute (NCI); University of California, Los AngelesCompletedHPV Vaccine | Adolescent Health | Vaccine | Immunization | Reproductive Health | Preventive Health Services | Human Papiloma Virus Vaccine | Health RegistryUnited States
-
University of Colorado, DenverRobert Wood Johnson FoundationTerminatedHealthyUnited States
-
University of California, Los AngelesNational Cancer Institute (NCI); University of Colorado, Denver; New York State...Completed
-
University of Colorado, DenverCenters for Disease Control and PreventionCompletedMeningococcal Infection | Varicella | Human Papilloma Virus (HPV) | Tetanus-diphtheria-acellular Pertussis (Tdap)
-
University of RochesterCenters for Disease Control and PreventionCompletedIncrease in Use of Immunization Registry | Increase in HPV Vaccination RateUnited States
-
University of Colorado, DenverCenters for Disease Control and PreventionCompletedImmunization RateUnited States
-
Stanford UniversityPatient-Centered Outcomes Research Institute; Duke UniversityWithdrawnAtherosclerotic Cardiovascular Disease
-
Marshfield Clinic Research FoundationActive, not recruiting